Cytokine 30-Plex Human Panel
Cytokine 30-Plex Human Panel
Invitrogen™

Cytokine 30-Plex Human Panel

The Cytokine Human Magnetic 30-Plex Panel for the Luminex™ platform is specifically designed for quantifying human cytokines, chemokines and growthRead more
Have Questions?
Catalog NumberQuantity
LHC6003M100 tests
Catalog number LHC6003M
Price (INR)
310,480.00
Online offer
Ends: 31-Dec-2025
477,644.00
Save 167,164.00 (35%)
Each
Add to cart
Quantity:
100 tests
Price (INR)
310,480.00
Online offer
Ends: 31-Dec-2025
477,644.00
Save 167,164.00 (35%)
Each
Add to cart
The Cytokine Human Magnetic 30-Plex Panel for the Luminex™ platform is specifically designed for quantifying human cytokines, chemokines and growth factors in serum, plasma, and tissue culture supernatant. By measuring 30 analytes simultaneously, the Luminex™ assay panel helps provide more data from each sample, saving both money and time compared to more traditional systems (such as ELISA) used in research. This assay may be run alone or in combination with other select Luminex™ singleplex kits. The panel employs magnetic beads, facilitating automation, decreasing hands-on time, and increasing throughput and precision. The panel is suitable for use with the Luminex™ 100™/200™, FLEXMAP 3D™, and MAGPIX™ systems.

Superior performance—accurate, reproducible, and sensitive quantitation of multiple proteins
High quality—fully qualified antibodies permit excellent specificity and sensitivity
Fast and easy protocols—perform your multiplex assay and analyze your data typically in less than one day

Comprehensive Human Analyte Panel
The Human Cytokine Magnetic 30-Plex Panel for the Luminex™ platform provides reagents for the accurate, reproducible, and sensitive quantitation of human proteins including:

CytoKines: G-CSF, GM-CSF, IFN-α, IFN-γ, IL-1β, IL-1RA , IL-2, IL-2R, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p40/p70), IL-13, IL-15, IL-17, TNF-α

Chemokines: Eotaxin, IP-10, MCP-1, MIG, MIP-1α, MIP-1β, RANTES

Growth factors: EGF, FGF-basic, HGF, VEGF

Luminex™ xMAP™ Technology—Effective and Proven Analytical Tool
The Human Cytokine Magnetic 30-Plex Panel is based on xMAP™ technology. The use of a suspension bead-based technology enables the multiplexing capabilities of the Luminex™ assays. Magnetic microspheres are internally dyed with red and infrared fluorophores of differing intensities. Each bead is given a unique number, or bead region, allowing differentiation of one bead from another. Beads covalently bound to different antibodies can be mixed in the same assay, utilizing a 96-well microplate format. Upon completion of the sandwich immunoassay, magnetic beads must be measured using a Luminex™ detection system (MAGPIX™, 100™/200™, or FLEXMAP 3D™). The instrument uses xPONENT™ software to distinguish bead color (analyte) and R-PE fluorescence intensity (assay signal strength) to quantify target(s).

Magnetic Beads Let You Do More with Your Time
Magnetic bead-based assays use Luminex™ MagPlex magnetic microsphere. All other assay components are the same as the equivalent Luminex™ polystyrene bead-based assays providing identical quality and consistency performance. MagPlex technology takes advantage of magnetic properties to simplify assay wash steps and maximize uniformity of results. Magnetic bead-based assays also enable automation, decrease hands-on time, and increase throughput and precision. Easy to use protocols allow you to get your results in as little as 3.5 hours. In addition, these assays are compatible with both vacuum and magnetic wash stations and work well with the MAGPIX™ system as well as other Luminex™ xMAP™ platforms.

More Validation for Confidence in Your Results
The Human Cytokine Magnetic 30-Plex Panel has been validated using the same rigorous criteria that distinguishes Luminex™ assays from other commercially available assays. With more than 20 years of experience, our fully qualified antibodies help ensure the specificity and sensitivity of our assays. When benchmarked against the competition, our multiplex products consistently deliver excellent results. Every singleplex kit and premixed multiplex kit comes with a product insert that outlines the specifications for each marker in the assay (see Documents section below).

Learn more about all Invitrogen™ assays for the Luminex™ platform.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Assay RangeSee product documentation
Assay SensitivitySee Certificate of Analysis
Bead TypeSee product documentation
ConjugateR-PE
Detection MethodFluorescence
For Use With (Equipment)Luminex™ Instruments
FormatPreconfigured Panel
Product LineNovex
ProteinCytokine
Protein SubtypeCytokines & Receptors
Sample TypeSerum, Plasma, Cell Culture Supernatants
Shipping ConditionWet Ice
CombinabilityCombinable
Product TypeMultiplex Panel
Quantity100 tests
Research AreaImmunology, Cytokines
SpeciesHuman
Unit SizeEach
Contents & Storage
Contains premixed antibody coated capture beads, standard, premixed detector antibody, diluents, SAV concentrate, buffers, wash solution, flat bottom plate, complete protocol and lot-specific technical data sheet. Store at 2°C to 8°C.

Frequently asked questions (FAQs)

Which instruments are compatible with the Cytokine Human Magnetic 30-Plex Panel?

The Cytokine Human Magnetic 30-Plex Panel is suitable for use with the Luminex 100/200, FLEXMAP 3D, and MAGPIX systems.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

During my ProcartaPlex assay data analysis, I am getting a warning message that there is high bead aggregation. What should I do?

Here are possible causes and solutions for this issue:

- Check the protocol settings (make sure you select the correct DD settings).
- Check the level of sheath fluid and empty the waste.
- Before acquiring the plate, run calibration and verification beads on the Luminex instrument.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

During my ProcartaPlex assay data analysis, the beads fall below or to the lower left of their bead region on the bead map. Why is this?

Here are possible causes and solutions for this issue:

This usually indicates that the beads have been photobleached. This problem can also be caused by exposing the beads to organic solvents. Unfortunately, the assay will have to be repeated because the beads cannot be restored. The beads must be protected from light and organic solvents.
Alternatively, the instrument may be off in its measurements or you may have a calibration issue. Call the manufacturer for a service appointment.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

During my ProcartaPlex assay data analysis, beads do not appear in the region gated. What happened?

This indicates that an incorrect buffer was used for the final step. The Wash Solution provided in the kit must be used for washing the beads and the Reading Buffer should be used for resuspending the beads before loading them into the Luminex instrument. The osmolarity of the solution will impact the size of the bead, and any change in the bead size will alter detection by the instrument.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

The bead counts for all of my ProcartaPlex assay wells are erratic. What went wrong?

Here are some suggestions:

- Before acquiring the plate, run calibration and verification beads on the Luminex instrument.
- Review the instrument settings and make sure they are appropriate for the assay being run (adjustment of needle height, make sure you select the correct bead gates and the correct DD settings).
- Shake the plate before acquisition on the instrument to resuspend the beads.
- Vortex the beads for 30 sec before adding them into the plate.
- Washing: Do not forget to keep the plate for about 2 mins on the Hand-Held Magnetic Plate Washer before emptying the plate.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Citations & References (10)

Citations & References
Abstract
Performance of multiplex commercial kits to quantify cytokine and chemokine responses in culture supernatants from Plasmodium falciparum stimulations.
Authors:Moncunill G, Aponte JJ, Nhabomba AJ, Dobaño C,
Journal:PLoS One
PubMed ID:23300981
'Cytokines and chemokines are relevant biomarkers of pathology and immunity to infectious diseases such as malaria. Several commercially available kits based on quantitative suspension array technologies allow the profiling of multiple cytokines and chemokines in small volumes of sample. However, kits are being continuously improved and information on their performance ... More
Alterations of gene expression and protein synthesis in co-cultured adipose tissue-derived stem cells and squamous cell-carcinoma cells: consequences for clinical applications.
Authors:Koellensperger E, Gramley F, Preisner F, Leimer U, Germann G, Dexheimer V
Journal:
PubMed ID:24887580
This is the first study evaluating the interactions of human adipose tissue derived stem cells (ADSCs) and human squamous cell carcinoma cells (SCCs), with regard to a prospective cell-based skin regenerative therapy and a thereby unintended co-localization of ADSCs and SCCs. ... More
High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T
Authors:Löhr M, Freitag B, Technau A, Krauss J, Monoranu CM, Rachor J, Lutz MB, Hagemann C, Kessler AF, Linsenmann T, Wölfl M, Ernestus RI, Engelhardt S, Gelbrich G, Schlegel PG, Eyrich M
Journal:Cancer Immunol Immunother
PubMed ID:30054667
'High-grade gliomas (HGG) exert systemic immunosuppression, which is of particular importance as immunotherapeutic strategies such as therapeutic vaccines are increasingly used to treat HGGs. In a first cohort of 61 HGG patients we evaluated a panel of 30 hematological and 34 plasma biomarkers. Then, we investigated in a second cohort ... More
Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.
Authors:Tchou J, Zhao Y, Levine BL, Zhang PJ, Davis MM, Melenhorst JJ, Kulikovskaya I, Brennan AL, Liu X, Lacey SF, Posey AD, Williams AD, So A, Conejo-Garcia JR, Plesa G, Young RM, McGettigan S, Campbell J, Pierce RH, Matro JM, DeMichele AM, Clark AS, Cooper LJ, Schuchter LM, Vonderheide RH, June CH
Journal:Cancer Immunol Res
PubMed ID:29109077
'Chimeric antigen receptors (CAR) are synthetic molecules that provide new specificities to T cells. Although successful in treatment of hematologic malignancies, CAR T cells are ineffective for solid tumors to date. We found that the cell-surface molecule c-Met was expressed in ~50% of breast tumors, prompting the construction of a ... More
Cell-Intrinsic Glycogen Metabolism Supports Early Glycolytic Reprogramming Required for Dendritic Cell Immune Responses.
Authors:Thwe PM, Pelgrom L, Cooper R, Beauchamp S, Reisz JA, D'Alessandro A, Everts B, Amiel E
Journal:Cell Metab
PubMed ID:28877459
'Dendritic cell (DC) activation by Toll-like receptor (TLR) agonists causes rapid glycolytic reprogramming that is required to meet the metabolic demands of their immune activation. Recent efforts in the field have identified an important role for extracellular glucose sourcing to support DC activation. However, the contributions of intracellular glucose stores ... More